×
Cooper Cash on Hand 2010-2024 | COO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cooper cash on hand for the quarter ending October 31, 2024 was
$0.108B
, a
10.93% decline
year-over-year.
Cooper cash on hand for 2024 was
$0.108B
, a
10.93% decline
from 2023.
Cooper cash on hand for 2023 was
$0.121B
, a
12.59% decline
from 2022.
Cooper cash on hand for 2022 was
$0.138B
, a
44.11% increase
from 2021.
View More
Cooper Cash on Hand 2010-2024 | COO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Cooper cash on hand for 2024 was
$0.108B
, a
10.93% decline
from 2023.
Cooper cash on hand for 2023 was
$0.121B
, a
12.59% decline
from 2022.
Cooper cash on hand for 2022 was
$0.138B
, a
44.11% increase
from 2021.
Related Stocks
Company Name
Market
Cap
McKesson (MCK)
$75.6B
Becton Dickinson (BDX)
$65.4B
Cardinal Health (CAH)
$30.8B
Straumann Holding AG (SAUHY)
$23.4B
Labcorp (LH)
$20.8B
Align Technology (ALGN)
$14.8B
West Pharmaceutical Services (WST)
$14.7B
Henry Schein (HSIC)
$9.7B
Merit Medical Systems (MMSI)
$6.2B
DENTSPLY SIRONA (XRAY)
$3.8B
Patterson (PDCO)
$2.7B
CONMED (CNMD)
$1.9B
STAAR Surgical (STAA)
$830M
Lifevantage (LFVN)
$211M
Pro-Dex (PDEX)
$109M